GLOBOCAN 2020: Bladder cancer 10th most commonly diagnosed worldwide
On 14th December, the International Agency for Research on Cancer (IARC) has published the updated GLOBOCAN 2020 with new estimates on the global cancer burden, indicating that it has risen to 19.3 million cases and 10 million cancer deaths in 2020.
The International Agency for Research on Cancer estimates that globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease. These new estimates suggest that more than 50 million people are living within five years of a past cancer diagnosis. Ageing populations globally and socio-economic risk factors remain among the primary factors driving this increase.
«The ongoing changes in population structure, the environments in which people live, and the extent to which health systems are capable of delivering effective cancer control interventions will together drive the scale and profile of cancer incidence, mortality, and prevalence that will emerge over the next decades.
Dr Freddie Bray, Head of the Section of Cancer Surveillance at IARC
The new data estimates that 573,278 people will be diagnosed with bladder cancer in 2020 around the world, placing bladder cancer as the 10th most commonly diagnosed cancer in the world.
The new data projects an estimated 440,864 new cases of bladder cancer in men worldwide, accounting for 4.4% of total new cases. Bladder cancer is estimated to be the 6th most commonly diagnosed cancer in men worldwide.
The new 5-year prevalence estimates also show that 1,720,625 people (all genders) are living with bladder cancer within five years of a past diagnosis.
The GLOBOCAN 2020 database, accessible online as part of the IARC Global Cancer Observatory, provides estimates for 2020 of incidence and mortality in 185 countries for 36 types of cancer and for all cancer sites combined.
For more information visit: https://www.iarc.fr/faq/latest-global-cancer-data-2020-qa/